Division of Neurosurgery, University Health Network, Toronto Western Hospital, University of Toronto; and.
J Neurosurg. 2014 Jul;121(1):75-83. doi: 10.3171/2014.3.JNS131679. Epub 2014 May 2.
OBJECT.: While the use of endoscopic approaches has become increasingly accepted in the resection of pituitary adenomas, limited evidence exists regarding the success of this technique for patients with large and giant pituitary adenomas. This study reviews the outcomes of a large cohort of patients with large and giant pituitary adenomas who underwent endoscopic endonasal transsphenoidal surgery at the authors' institution and focuses on identifying factors that can predict extent of resection and hence aid in developing guidelines and indications for the use of endoscopic endonasal transsphenoidal surgery versus open craniotomy approaches to large and giant pituitary adenomas.
The authors reviewed 487 patients who underwent endoscopic endonasal transsphenoidal resection of sellar masses. From this group, 73 consecutive patients with large and giant pituitary adenomas (defined as maximum diameter ≥ 3 cm and tumor volume ≥ 10 cm(3)) who underwent endoscopic endonasal transsphenoidal surgery between January 1, 2006, and June 6, 2012, were included in the study. Clinical presentation, radiological studies, laboratory investigations, tumor pathology data, clinical outcomes, extent of resection measured by volumetric analysis, and complications were analyzed.
The mean preoperative tumor diameter in this series was 4.1 cm and the volume was 18 cm(3). The average resection rate was 82.9%, corresponding with a mean residual volume of 3 cm(3). Gross-total resection was achieved in 16 patients (24%), near-total in 11 (17%), subtotal in 24 (36%), and partial in 15 (23%). Seventy-three percent of patients experienced improvement in visual acuity, while 24% were unchanged. Visual fields were improved in 61.8% and unchanged in 5.5%. Overall, 27 patients (37%) experienced a total of 32 complications. The most common complications were sinusitis (14%) and CSF leak (10%). Six patients underwent subsequent radiation therapy because of aggressive tumor histopathology. No deaths occurred in this cohort of patients. Statistically significant predictors of extent of resection included highest Knosp grade (p = 0.001), preoperative tumor volume (p = 0.025), preoperative maximum tumor diameter (p = 0.002), hemorrhagic component (p = 0.027), posterior extension (p = 0.001), and sphenoid sinus invasion (p = 0.005).
Endoscopic endonasal transsphenoidal surgery is an effective treatment method for patients with large and giant pituitary adenomas, which results in high (> 80%) rates of resection and improvement in visual function. It is not associated with high rates of major complications and is safe when performed by experienced surgeons. The preoperative Knosp grade, tumor volume, tumor diameter, hemorrhagic components on MRI, posterior extension, and sphenoid sinus invasion may allow a prediction of extent of resection and in these patients a staged operation may be required to maximize extent of resection.
虽然内镜入路在垂体腺瘤切除中越来越被接受,但对于大型和巨大型垂体腺瘤患者,这种技术的成功率的相关证据有限。本研究回顾了在作者机构接受内镜经鼻蝶窦入路手术的一组大型和巨大型垂体腺瘤患者的结果,并重点确定了可以预测切除程度的因素,从而有助于制定内镜经鼻蝶窦入路手术与开颅手术治疗大型和巨大型垂体腺瘤的指南和适应证。
作者回顾了 487 例接受经蝶窦鞍内肿块内镜切除术的患者。在此基础上,纳入了 73 例连续的大型和巨大型垂体腺瘤患者(定义为最大直径≥3cm,肿瘤体积≥10cm3),这些患者于 2006 年 1 月 1 日至 2012 年 6 月 6 日期间接受了内镜经鼻蝶窦入路手术。分析了临床特征、影像学研究、实验室检查、肿瘤病理数据、临床结果、肿瘤体积分析的切除程度以及并发症。
本系列的术前平均肿瘤直径为 4.1cm,体积为 18cm3。平均切除率为 82.9%,对应的平均残留体积为 3cm3。大体全切除 16 例(24%),近全切除 11 例(17%),次全切除 24 例(36%),部分切除 15 例(23%)。73%的患者视力改善,24%无变化。视力视野改善 61.8%,无变化 5.5%。总体而言,27 例(37%)患者共发生 32 例并发症。最常见的并发症是鼻窦炎(14%)和脑脊液漏(10%)。6 例患者因肿瘤侵袭性组织病理学表现而接受后续放射治疗。该组患者无死亡病例。与切除程度显著相关的预测因素包括 Knosp 分级最高(p=0.001)、术前肿瘤体积(p=0.025)、术前最大肿瘤直径(p=0.002)、出血成分(p=0.027)、后向延伸(p=0.001)和蝶窦侵袭(p=0.005)。
内镜经鼻蝶窦入路手术是治疗大型和巨大型垂体腺瘤的有效方法,可实现较高(>80%)的切除率和视觉功能改善。与高并发症发生率无关,在经验丰富的外科医生操作时是安全的。术前 Knosp 分级、肿瘤体积、肿瘤直径、MRI 上的出血成分、后向延伸和蝶窦侵袭可能可以预测切除程度,在这些患者中,可能需要分期手术以最大限度地提高切除程度。